BSS
Active substance: SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, SODIUM CITRATE
SOLUTION · SODIUM CHLORIDE 6.4 mg/mL, POTASSIUM CHLORIDE .75 mg/mL, CALCIUM CHLORIDE .48 mg/mL, MAGNESIUM CHLORIDE .3 mg/mL, SODIUM ACETATE 3.9 mg/mL, SODIUM CITRATE 1.7 mg/mL
United StatesActive
Marketing holder: Alcon Laboratories, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SODIUM CHLORIDE · 6.4 mg/mL
- POTASSIUM CHLORIDE · .75 mg/mL
- CALCIUM CHLORIDE · .48 mg/mL
- MAGNESIUM CHLORIDE · .3 mg/mL
- SODIUM ACETATE · 3.9 mg/mL
- SODIUM CITRATE · 1.7 mg/mL
Registration
- Registration number
- 0065-1795
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- OPHTHALMIC
Sources
- product · openFDA NDC · 0065-1795 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0065-1795 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0065-1795 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0065-1795 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 0065-1795 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 0065-1795 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 0065-1795 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 0065-1795 · Verified 2026-10-09 · open in source